Clinical Trials Browser

Phase 2 × donafenib × Endocrine × Clear all

NCT02870569 2019-03-01

Phase 2 Trial of Donafenib in 131I-Refractory Differentiated Thyroid Cancer

Phase 2 Completed

EndocrineHead & Neck

Differentiated Thyroid Cancer